Nektar Therapeutics (NKTR)
37.11
+0.58
(+1.59%)
USD |
NASDAQ |
Jan 23, 16:00
37.09
-0.02
(-0.05%)
After-Hours: 20:00
Nektar Therapeutics Research and Development Expense (TTM): 116.36M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 28.24M |
| Insmed, Inc. | 695.91M |
| Eli Lilly & Co. | 12.56B |
| Ironwood Pharmaceuticals, Inc. | 95.29M |
| Lyell Immunopharma, Inc. | 140.98M |